Lars Ekman Ultragenyx Pharmaceutical Inc. (RARE) insider trading activity

RARE Quotes by TradingView

Lars Ekman is Director of Ultragenyx Pharmaceutical Inc.. Currently has a direct ownership of 17,745 shares of RARE, which is worth approximately $894,880. The most recent transaction as insider was on Jun 24, 2022, when has been sold 3,300 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 17.7K
0% 3M change
0% 12M change
Total Value Held $894,880

Lars Ekman Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jun 24 2022
BUY
Grant, award, or other acquisition
-
3,300 Added 15.68%
17,745 Common Stock
Jun 24 2021
BUY
Grant, award, or other acquisition
-
2,145 Added 12.93%
14,445 Common Stock

Also insider at

PRTA
PROTHENA CORP PUBLIC LTD CO Healthcare
AMRN
AMARIN CORP PLCUK Healthcare
LE

Lars Ekman

Director
South San Francisco, CA

Track Institutional and Insider Activities on RARE

Follow Ultragenyx Pharmaceutical Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells RARE shares.

Notify only if

Insider Trading

Get notified when an Ultragenyx Pharmaceutical Inc. insider buys or sells RARE shares.

Notify only if

News

Receive news related to Ultragenyx Pharmaceutical Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on RARE